dexloxiglumide

DRUG2 trials

Sponsors

Rottapharm, Forest Laboratories

Conditions

DyspepsiaIrritable Bowel Syndrome

Phase 2

The Safety and Efficacy of Dexloxiglumide for the Relief of Symptoms of Functional Dyspepsia.

CompletedNCT00303264

Forest LaboratoriesDyspepsia

Start: 2006-05-31End: 2007-08-31Updated: 2012-03-05

Phase 3

DARWIN Study: A Randomization/Withdrawal Efficacy Study of Dexloxiglumide in Constipation-Predominant Irritable Bowel Syndrome (C-IBS)

CompletedNCT00220090

RottapharmIrritable Bowel Syndrome

Start: 2003-07-31Updated: 2008-05-14